Arterial stiffness is related to systemic inflammation in essential hypertension

Hypertension

Volumn 46, Issue 5, 2005, Pages 1118-1122

  Mahmud, Azra ^a   Feely, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Arteries; Atherosclerosis; Elasticity; Endothelium; Hypertension, arterial

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; RIGIDITY; RISK FACTOR; SYSTEMIC VASCULITIS;

ARTERIES; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PULSE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27444441660     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000185463.27209.b0     Document Type: Article

References (33)

1. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
2. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106:2085-2090.
3. Blacher J, London GM, Safar B, Mourad J-J. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. J Hypertens. 1999;17:237-244.
4. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434-438.
5. Weber T, Auer J, O'Rourke MF, Kvas E, Lannig E, Bereent R, Eber B. Arterial stiffness, wave reflections and the risk of coronary artery disease. Circulation. 2004;109:184-189.
6. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399-403.
7. Hashimoto H. Kitagawa K, Hougaku H, Etani H, Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke. 2004;35:1625-1630.
8. Amar J, Ruidavets JB, Sollier CB, Bongard V, Boccalon H, Chamontin B, Drouet L, Ferrieres J. Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. J Hypertens. 2004;22:349-355.
9. Pai JK, Pischon T, Ma J Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351:2599-2610.
10. Bautista LE, Veram LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension. J Hum Hypertens. 2005;19:149-154.
11. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24: 969-974.
12. Kampus R, Kals J, Ristimãe T, Fischer K, Zilmer M, Teesalu R. High sensitivity C-reactive protein affects central hemodynamics and augmentation index in apparently healthy persons. J Hypertens. 2005;22: 1133-1139.
13. Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR, Wilkinson IB. Inflammation and arterial stiffness in systemic vasculitis. a model of vascular inflammation. Arthritis Rheum. 2004;50:581-588.
14. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525:263-267.
15. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens. 2004;26:637-644.
16. Gatzka CD, Cameron JD, Dart AM, Barry KL, Kingwell BA, Dewar EM, Reid CM, Jennings GL. Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the Elderly. Am J Hypertens. 2001;14:573-577.
17. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-Reactive protein in healthy subjects; associations with obesity, insulin resistance and endothelial dysfunction: a potential role of cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972-978.
18. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Wasterhof N, Stehouwer CD. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004;43:176-181.
19. Yasmin, Wallace S, McEniery CM, Dakham Z, Pusalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:372-378.
20. Mahmud A, Feely J. Arterial stiffness and the renin-angiotensin- aldosterone system. J Renin Angiotensin Aldosterone Syst. 2004;5:102-108.
21. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994-999.
22. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000; 102:1000-1006.
23. Yasmin, Brown MJ. Determinants of arterial stiffness in offspring of families with essential hypertension. Am J Hypertens. 2004;17:292-298.
24. Bassuk SS, Rifai N, Ridker PM. High sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29:439-493.
25. Wilkinson IB, MacCallum H, Cockcroft JR, Webb DJ. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol. 2002;53:189-192.
26. Mattace-Raso FU, van der Cammen TJM, van der Meer IM, Schalekamp MA, Asmar R, Hofman A, Witteman JC. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis. 2004;176: 111-116.
27. Mahmud A, Feely J. Reduction in Arterial Stiffness with Angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens. 2002;15:321-325.
28. Takeda T, Hoshida S, Nishino M, Tanouchi J, Otsu K, Hori M. Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis. 2003;169: 155-158.
29. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first ever ischemic stroke. Stroke. 2003;34:2922-2929.
30. Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona P. Evidence for a potent anti-inflammatory effect of rosiglitazone. J Clin Endocrinol Metab. 2004;89: 2728-2735.
31. Ichihara A, Hayashi M, Koura Y, Tada Y, Kaneshiro Y, Saruta T. Long term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens. 2005;19:103-109.
32. Nakamura T, Matsuda T, Kawagoe Y, Ogawa H, Takahashi Y, Sekizuka K, Koide H. Effect of pioglitazone on carotid antima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients. Metabolism. 2004;53:1382-1386.
33. Ridker PM, Cannon CP, Morrow D, Riffai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E. C-Reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20-28.